FindTrial
Sign In

Details of patients with Hepatocellular cancer in various centre

Demographic profile of hepatocellular carcinoma in three tertiary care referral centres

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/03/012578
Enrollment
500
Registered
2018-03-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Hepatocellular cancer Health Condition 2: C220- Liver cell carcinoma

Interventions

None listed

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -All patients with a diagnosis of hepatocellular carcinoma. -HCC will be diagnosed according to Modified European Association for study of Liver (EASL) criteria which includes either biopsy or any two of the following three: a. AFP >300 ng/dl b. Arterial enhancement and venous phase washout on CECT c. Arterial enhancement and venous phase washout on MRI. Staging of HCC will be done according to Barcelona Clinic Liver Cancer (BCLC) classification.

Exclusion criteria

Exclusion criteria: Other space occupying lesions in liver like metastasis or primary benign tumors will be excluded from the study

Design outcomes

Primary

MeasureTime frame
To analyze the demographic characteristics, clinical presentation, etiological profile and tumour characteristics of patients of HCC presenting to any of the three tertiary care institutions in MumbaiTimepoint: 24 months—

Secondary

MeasureTime frame
Demographic profile Clinical presentation Etiology Timepoint: 24 months—

Countries

India

Contacts

Public ContactDr Mahesh Goel

Tata Memorial Hospital

drmaheshgoel@gmail.com9820504492

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026